Valuation : China Shineway Pharmaceutical Group Limited

Market Cap 513.7Cr 600.54Cr 77Cr 66Cr 62Cr 57Cr 106.23Cr 7.32TCr 106.76Cr 741.94Cr 285.31Cr 3.72TCr 287.57Cr 281.26Cr 12TCr P/E 2026 *
6.8x
P/E 2027 * 6.33x
Enterprise Value 513.7Cr 600.54Cr 77Cr 66Cr 62Cr 57Cr 106.23Cr 7.32TCr 106.76Cr 741.94Cr 285.31Cr 3.72TCr 287.57Cr 281.26Cr 12TCr EV / Sales 2026 *
2.19x
EV / Sales 2027 * 2.19x
Free-Float
33.69%
Yield 2026 *
-
Yield 2027 * -
1 day-4.33%
1 week-3.75%
Current month-4.16%
1 month-1.49%
3 months-4.68%
6 months-14.61%
Current year-7.56%
1 week 7.58
Extreme 7.58
8.42
1 month 7.58
Extreme 7.58
8.93
Current year 7.21
Extreme 7.21
10.47
1 year 7.21
Extreme 7.21
10.47
3 years 6.55
Extreme 6.55
10.76
5 years 4.63
Extreme 4.63
10.76
10 years 4.6
Extreme 4.6
18.54
Manager TitleAgeSince
Investor Relations Contact 60 -
Sales & Marketing 46 01/12/2019
Comptroller/Controller/Auditor 53 01/02/2011
Director TitleAgeSince
Chairman 70 14/08/2002
Director/Board Member 62 14/08/2002
Director/Board Member 58 -
Date Insider Type Main position Quantity % Market Cap. Importance
31/10/22 Other

Director

2,80,000 0.0339%
Change 5-day change 1-year change 3-year change Capi.($)
-4.33%-3.75%-9.56%+6.85% 77Cr
-1.13%-3.11%+13.82%+60.66% 4.62TCr
-1.13%-5.78%+33.26%+108.13% 3.88TCr
+0.12%-0.08%+7.12%+78.27% 1.17TCr
-0.53%-1.37%-13.25%+10.18% 1.16TCr
-0.38%-2.26%+18.18%+139.63% 913.65Cr
+0.32%-2.26%+23.08%+34.73% 730.05Cr
+0.17%-0.74%+13.44%+197.13% 714.6Cr
-1.00%-5.25%+34.34%-19.63% 709.83Cr
-3.13%-4.30%-44.88%+11.66% 496.76Cr
Average -1.10%-2.71%+7.56%+62.76% 1.45TCr
Weighted average by Cap. -0.88%-3.27%+15.92%+75.29%

Financials

2026 *2027 *
Net sales 234.4Cr 274.03Cr 35Cr 30Cr 29Cr 26Cr 48Cr 3.34TCr 49Cr 338.54Cr 130.19Cr 1.7TCr 131.22Cr 128.34Cr 5.37TCr 234.7Cr 274.38Cr 35Cr 30Cr 29Cr 26Cr 49Cr 3.34TCr 49Cr 338.98Cr 130.35Cr 1.7TCr 131.39Cr 128.5Cr 5.37TCr
Net income 76Cr 88Cr 11Cr 9.7Cr 9.18Cr 8.32Cr 16Cr 1.08TCr 16Cr 109.04Cr 42Cr 546.99Cr 42Cr 41Cr 1.73TCr 81Cr 95Cr 12Cr 10Cr 9.86Cr 8.94Cr 17Cr 1.15TCr 17Cr 117.13Cr 45Cr 587.57Cr 45Cr 44Cr 1.86TCr
Net Debt - -
Logo China Shineway Pharmaceutical Group Limited
China Shineway Pharmaceutical Group Ltd is an investment holding company primarily engaged in research and development, manufacturing and trading of Chinese pharmaceutical products. The Company’s product dosage forms include injections, soft capsules, granules, traditional Chinese medicine (TCM) granules, oral products and other dosage forms. The Company’s products include Qing Kai Ling Injection, Shen Mai Injection, Wu Fu Xin Nao Qing Soft Capsule, Qing Kai Ling Soft Capsule, Huamoyan Granule, Compound Licorice Tablet and other products, applied to influenza, cardio-cerebrovascular, respiratory system and other disease fields. The Company operates its business in mainland China and Hong Kong markets.
Employees
2,822
Date Price Change Volume
11/26/11 HK$7.950 -4.33% 29,03,000
10/26/10 HK$8.310 +0.12% 54,05,000
09/26/09 HK$8.300 -1.01% 61,94,475
08/26/08 HK$8.385 +2.38% 29,39,000
07/26/07 HK$8.190 -0.85% 14,08,000
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
6.800CNY
Average target price
7.294CNY
Spread / Average Target
+7.26%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 2877 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!